Clinical risk management of interactions between natural products and drugs
Peter A G M De Smet1, Annemieke Floor-Schreudering, Marcel L Bouvy
1Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. pdesmet@winap.nl
Abstract:
Clinical risk management offers a systematic approach to minimize healthcare-related risks by paying attention to: (1) risk identification and assessment; (2) development and execution of risk reduction strategies; (3) evaluation of risk reduction strategies. This paper reviews these key areas for the risk of interactions between natural products and drugs (NPDIs) to explore how the impact of these interactions on public health can be minimized. It argues that specific components of clinical risk management need to be evaluated, before adoption, and then actively implemented if proven valuable.
Related Concept Videos
Pharmacokinetics: Drug–Drug Interactions
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Drug toxicity: Drug–Drug Interaction
Drug Toxicity: Risk factors
Drug toxicity: Idiosyncratic Reactions
Pharmaceutical Poisoning: Potential Scenarios

